Viking Global Investors LP Moderna, Inc. Transaction History

Viking Global Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$29.67 - $80.0 $29.5 Million - $79.6 Million	-994,886 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$17.78 - $31.58 $41.4 Million - $73.5 Million	-2,326,869 Reduced 70.05%	994,886 $29.8 Million
Q4 2019 Feb 13, 2020	SELL	$13.93 - $21.28 $18.9 Million - $28.9 Million	-1,356,026 Reduced 28.99%	3,321,755 $65 Million
Q3 2019 Nov 13, 2019	SELL	$12.26 - $18.07 $43.2 Million - $63.6 Million	-3,519,677 Reduced 42.94%	4,677,781 $74.5 Million
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $116 Million - $240 Million	-8,470,408 Reduced 50.82%	8,197,458 $120 Million
Q1 2019 May 15, 2019	SELL	$14.45 - $23.7 $5.97 Million - $9.8 Million	-413,298 Reduced 2.42%	16,667,866 $339 Million
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $231 Million - $321 Million	17,081,164 New	17,081,164 $261 Million

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.